Aequus Pharmaceuticals Inc. (TSXV:AQS)
0.0050
0.00 (0.00%)
Apr 25, 2025, 8:30 AM EST
Aequus Pharmaceuticals Revenue
In the year 2024, Aequus Pharmaceuticals had annual revenue of 332.30K CAD with 131.31% growth.
Revenue
332.30K
Revenue Growth
+131.31%
P/S Ratio
0.72
Revenue / Employee
n/a
Employees
12
Market Cap
663.17K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 332.30K | 188.64K | 131.31% |
| Dec 31, 2023 | 143.66K | -1.24M | -89.59% |
| Dec 31, 2022 | 1.38M | -1.33M | -49.17% |
| Dec 31, 2021 | 2.71M | 122.09K | 4.71% |
| Dec 31, 2020 | 2.59M | 960.09K | 58.81% |
| Dec 31, 2019 | 1.63M | 222.28K | 15.76% |
| Dec 31, 2018 | 1.41M | 270.82K | 23.77% |
| Dec 31, 2017 | 1.14M | 437.79K | 62.40% |
| Dec 31, 2016 | 701.63K | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayurcann Holdings | 31.28M |
| Vibe Growth | 22.19M |
| Adastra Holdings | 16.86M |
| Vencanna Ventures | 3.60M |
| Optimind Pharma | 131.48K |
| Genix Pharmaceuticals | 68.00 |
| Planet Based Foods Global | -356.97K |
| Captor Capital | -1.18M |
Aequus Pharmaceuticals News
- 3 months ago - Aequus Provides Additional Disclosure in Connection with Annual General and Special Meeting of Shareholders - TheNewswire
- 3 months ago - Aequus Provides Additional Disclosure in Connection with Annual General and Special Meeting of Shareholders - TheNewswire
- 5 months ago - Aequus Announces Giovanni Di Genova Joining Board of Directors - TheNewswire
- 9 months ago - Aequus Pharmaceuticals announces sale of Zimed PF to Luvo Medical Technologies - Seeking Alpha
- 9 months ago - Aequus Announces Sale of Zimed PF to Luvo Medical Technologies - TheNewswire
- 9 months ago - Aequus Pharmaceuticals reports Q1 results - Seeking Alpha
- 9 months ago - Aequus Reports First Quarter 2025 Financial Highlights - TheNewswire
- 1 year ago - Aequus Pharmaceuticals reports Q3 results - Seeking Alpha